Reeovision

Company Overview

Snapshot

Founded in January 2023 by Ronen Einat and Yaniv Barkana, Reeovision operates with 1–10 employees. Reeovision is currently in the R&D product stage, focusing on developing advanced medical imaging solutions.

Business overview

Reeovision is pioneering a breakthrough in medical imaging with its innovative Optical Coherence Tomography (OCT) device. This technology aims to provide full-volume 3D mapping alongside other imaging modalities, addressing the limitations of current OCT tools that rely on sparse, line-based scans. By utilizing a full-field imaging technique, Reeovision's device offers high spatial resolution and simplified implementation, enabling multi-modality data capture with the same receive optics. The company's solution combines full-volume OCT with regular imaging modalities like RGB imaging and fluorescence, resulting in a compact and cost-effective device designed to enhance diagnostic quality, improve abnormality measurements, and support AI-based diagnostics development. Reeovision primarily serves the ophthalmology segment within the Health Tech & Life Sciences sector, targeting markets in Europe, East Asia, and North America.

Company Intelligence Q&A

When was Reeovision founded?

Reeovision was founded in January 2023.

Who are the founders of Reeovision?

The founders of Reeovision are Ronen Einat and Yaniv Barkana.

What is Reeovision's primary focus in medical imaging?

Reeovision is focused on developing an Optical Coherence Tomography (OCT) device that combines full-field OCT and fundus imaging for full-volume 3D mapping in ophthalmology.

What markets does Reeovision target?

Reeovision targets geomarkets including Europe, East Asia, and North America.

What is Reeovision's total funding to date?

Reeovision has raised a total of $25K across one funding round.